Resistance Training in Relapsing-Remitting Multiple Sclerosis

被引：1
|
作者：
Dalgas, U. [1 ]
Kant, M.
Stenager, E. [2 ]
机构：
[1] Univ Aarhus, Dept Sport Sci, DK-8000 Aarhus C, Denmark
[2] Univ So Denmark, Inst Reg Hlth Serv Res, Odense, Denmark
来源：
AKTUELLE NEUROLOGIE | 2010年 / 37卷 / 05期
关键词：
exercise therapy; strength training; fatigue; quality of life; rehabilitation; QUALITY-OF-LIFE; FUNCTIONAL-CAPACITY; GAIT KINEMATICS; EXERCISE; STRENGTH; PEOPLE; FATIGUE; RISK;
D O I：
10.1055/s-0030-1248526
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
This review summarises the existing knowledge regarding the effects of resistance training in patients suffering from relapsing-remitting multiple sclerosis (MS). Also, the literature concerning the effects of exercise on both the MS animal model and the immune system in MS patiente are reviewed. It is concluded that resistance training is a safe and beneficial exercise modality inmoderately impaired MS patients, potentially improving muscle strength, muscle mass, functional capacity, fatigue, mood and quality of life. Exercise may influence the disease progression in MS patients, but further studies are needed.
引用
收藏
页码：213 / 218
页数：6
相关论文
共 50 条
  • [31] Postural Control in Relapsing-Remitting Multiple Sclerosis
    Cusin, Flavia Salvaterra
    Tomaz, Andreza
    Gananca, Mauricio Malavasi
    Oliveira, Enedina Maria
    Falcao Goncalves, Alessandra Billi
    Caovilla, Heloisa Helena
    [J]. INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY, 2022, 26 (04) : 592 - 604
  • [32] Current management of relapsing-remitting multiple sclerosis
    Sedal, L.
    Wilson, I. B.
    McDonald, E. A.
    [J]. INTERNAL MEDICINE JOURNAL, 2014, 44 (10) : 950 - 957
  • [33] Oral fingolimod for relapsing-remitting multiple sclerosis
    Doggrell, Sheila A.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (10) : 1777 - 1781
  • [34] Cognitive Impairment In Relapsing-Remitting Multiple Sclerosis
    Topcular, Baris
    Ozcan, M. Emin
    Kurt, Elif
    Kuscu, Demet Yandim
    Icen, Nilufer Kale
    Sutlas, Pakize Nevin
    Kirbas, Dursun
    Bingol, Ayhan
    [J]. NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2012, 49 (03): : 178 - 182
  • [35] Natalizumab in spinal relapsing-remitting multiple sclerosis
    Zecca, C.
    Kamm, C.
    Riccitelli, G. C.
    Heldner, M.
    Caporro, M.
    Gobbi, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 457 - 457
  • [36] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Hersh, Carrie M.
    Cohen, Jeffrey A.
    [J]. IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
  • [37] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [38] Development of laquinimod for relapsing-remitting multiple sclerosis
    Jeffery, Douglas R.
    [J]. FUTURE NEUROLOGY, 2008, 3 (06) : 641 - 648
  • [39] Intravenous immunoglobulin in relapsing-remitting multiple sclerosis
    Achiron, A
    Barak, Y
    SarovaPinhas, I
    Achiron, R
    Gabbay, U
    Rotstein, Z
    Noy, S
    [J]. INTRAVENOUS IMMUNOGLOBULIN: RESEARCH AND THERAPY, 1996, : 289 - 293
  • [40] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
12345